Gene · 4486
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic Influences in Cancer-Associated Myositis. | Arthritis Rheumatol | 2023 | 36053262 | PubTator, text mining | PubMed |
| Immune cell-specific smoking-related expression characteristics are revealed by re-analysis of transcriptomes from the CEDAR cohort. | Cent Eur J Immunol | 2022 | 36817262 | PubTator, text mining | PubMed |
| Severe COVID-19 May Impact Hepatic Fibrosis /Hepatic Stellate Cells Activation as Indicated by a Pathway and Population Genetic Study. | Genes (Basel) | 2022 | 36672763 | PubTator, text mining | PubMed |
| Endometrial small extracellular vesicles regulate human trophectodermal cell invasion by reprogramming the phosphoproteome landscape. | Front Cell Dev Biol | 2022 | 36619864 | PubTator, text mining | PubMed |
| Intrinsic and Extrinsic Transcriptional Profiles That Affect the Clinical Response to PD-1 Inhibitors in Patients with Non-Small Cell Lung Cancer. | Cancers (Basel) | 2022 | 36612193 | PubTator, text mining | PubMed |
| Regulation of Kinase Signaling Pathways by α6β4-Integrins and Plectin in Prostate Cancer. | Cancers (Basel) | 2022 | 36612146 | PubTator, text mining | PubMed |
| Novel CSF Biomarkers Tracking Autoimmune Inflammatory and Neurodegenerative Aspects of CNS Diseases. | Diagnostics (Basel) | 2022 | 36611365 | PubTator, text mining | PubMed |
| Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections. | Front Immunol | 2022 | 36582222 | PubTator, text mining | PubMed |
| Conformation specific antagonistic high affinity antibodies to the RON receptor kinase for imaging and therapy. | Sci Rep | 2022 | 36581692 | PubTator, text mining | PubMed |
| Quantitative Proteomic Analysis of Serum Reveals MST1 as a Potential Candidate Biomarker in Spontaneously Diabetic Cynomolgus Monkeys. | ACS Omega | 2022 | 36570245 | PubTator, text mining | PubMed |
| Identification of necroptosis subtypes and development of necroptosis-related risk score model for in ovarian cancer. | Front Genet | 2022 | 36568363 | PubTator, text mining | PubMed |
| Insights into Lipid-Based Delivery Nanosystems of Protein-Tyrosine Kinase Inhibitors for Cancer Therapy. | Pharmaceutics | 2022 | 36559200 | PubTator, text mining | PubMed |
| Pancreatic Cancer: Beyond Brca Mutations. | J Pers Med | 2022 | 36556296 | PubTator, text mining | PubMed |
| Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer. | J Pers Med | 2022 | 36556227 | PubTator, text mining | PubMed |
| The VEGF/VEGFR Axis Revisited: Implications for Cancer Therapy. | Int J Mol Sci | 2022 | 36555234 | PubTator, text mining | PubMed |
| Kinase Inhibitors in the Treatment of Ovarian Cancer: Current State and Future Promises. | Cancers (Basel) | 2022 | 36551745 | PubTator, text mining | PubMed |
| Sialyltransferases and Neuraminidases: Potential Targets for Cancer Treatment. | Diseases | 2022 | 36547200 | PubTator, text mining | PubMed |
| Epigenetics and genetics of hepatoblastoma: Linkage and treatment. | Front Genet | 2022 | 36531231 | PubTator, text mining | PubMed |
| A detailed analysis of F-MuLV- and SFFV-infected cells in Friend virus-infected mice reveals the contribution of both F-MuLV- and SFFV-infected cells to the interleukin-10 host response. | Retrovirology | 2022 | 36527061 | PubTator, text mining | PubMed |
| Identification of molecular subtypes based on liquid-liquid phase separation and cross-talk with immunological phenotype in bladder cancer. | Front Immunol | 2022 | 36518754 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4486/papers?page=11